Predict your next investment

HEALTHCARE | Drug Discovery
acaciabio.com

See what CB Insights has to offer

Founded Year

1995

Stage

Acquired | Acquired

Total Raised

$1M

About Acacia Biosciences

Acacia Biosciences is a drug discovery technology company committed to the creation of proprietary assay systems and databases that facilitate the rapid development of biopharmaceuticals and agricultural chemicals. The Genome Reporter Matrix is the first in a series of novel tools that provide practical analysis of early stage chemicals by interpreting their effects across entire genomes. In addition to the GRM, Acacia ’s technology is used to discover novel targets and gene regulatory mechanisms.

Acacia Biosciences Headquarter Location

San Pablo, California, 94806,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.